<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20171228038117N2</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2018-02-11</date_registration>
      <primary_sponsor>Semnan University of Medical Sciences</primary_sponsor>
      <public_title>Comparing Spinal and General Anesthesia in terms of Postoperative Pain inPatients Undergoing Hysterectomy</public_title>
      <acronym></acronym>
      <scientific_title>Comparing Spinal and General Anesthesia in terms of Postoperative Pain inPatients Undergoing Hysterectomy</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2016-11-21</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>50</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/28634</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: simple randomization, Blinding description: Participants were unaware of the type of anesthesia.</study_design>
      <phase>3</phase>
      <hc_freetext>Post Hysterectomy pain.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: After anesthetic monitoring including pulse oximetry, ECG and blood pressure monitoring, premedication was administered by injecting benzodiazepine (intravenous midazolam, 2 mg) and a synthetic narcotic (intravenous fentanyl, 1 mg/kg body weight). GA was induced by injecting intravenous thiopental sodium 5 mg/kg bw, and the muscle relaxant, Atracurium, 0.5 mg/kg bw. After endotracheal intubation, inhalation anesthetic(including equal proportions of oxygen and Nitrous oxide, 4 L/min) and evaporation anesthetic (halogenated anesthetic: Isoflurane 1.2%, 1 MAC) were administered to maintainanesthesia and patients underwent mechanical ventilation using anesthesia ventilators.The patient was extubated at the end of the operation after discontinuing anesthetics and reversing the effects of the muscle relaxants using anticholineste rasessuch asneostigmine 40-70 µg/kg bw and anticholinergicssuch asintramuscular atropine 15µg/kg b w. They were then transferred to PACU (recovery room). Intervention 2: Control group: After anesthetic monitoring of the patient, including pulse oximetry, ECG and blood pressure monitoring, minimal 500 cc crytalloids serum was intravenously administered to prevent hypotension secondary to SA. After placing the patient in a seated position and using povidone-iodine solution for sterilizing the site of lumbar puncture, the L4/L5intervertebral space was identified. A cutting-tipped 25-gauge (orange) spinal needle was inserted into the intrathecal area, and the accuracy of the technique was ensured by the appearance of cerebrospinal fluid. A total of 3 cc hyperbaric bupivacaine solution 0.5%was then injected into the subarachnoid space and the patient was placed in supine position. After stabilizing SA, the position was adjusted so as to allow the local anesthetic to move toward the T8 area. A needle or alcohol-soaked cotton was used to identify the anesthetic area and the operation began after this area was stabilized. In case of agitation during operation, 1-2 mg of intravenous midazolam was administered, and the patient was transferred to PACU after the operation.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is Needs to review</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Babak Hoseinzadeh zorofchi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Department of Anesthesiology,Kosar Hospital,Semnan University of Medical Sciences,Semnan</address>
        <city>Semnan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3517816615</zip>
        <telephone>+98 23 3343 7838</telephone>
        <email>babak.hoseinzadeh@semums.ac.ir</email>
        <affiliation>Semnan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Babak Hoseinzadeh zorofchi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Department of Anesthesiology, Kosar Hospital,Semnan University of Medical Sciences, Semnan</address>
        <city>Semnan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3517816615</zip>
        <telephone>+98 23 3343 7838</telephone>
        <email>babak.hoseinzadeh@semums.ac.ir</email>
        <affiliation>Semnan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>American Society of Anesthesiologists (ASA) I and II class
Candidate for hysterectomy</inclusion_criteria>
      <agemin>20 years</agemin>
      <agemax>70 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>Prefer a specific method of anesthesia
Psychiatric diseases under medical treatment
Patients with chronic or acute pain
An anatomical disorder that requires a specific anesthetic method</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Treatment - Drugs</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: After anesthetic monitoring including pulse oximetry, ECG and blood pressure monitoring, premedication was administered by injecting benzodiazepine (intravenous midazolam, 2 mg) and a synthetic narcotic (intravenous fentanyl, 1 mg/kg body weight). GA was induced by injecting intravenous thiopental sodium 5 mg/kg bw, and the muscle relaxant, Atracurium, 0.5 mg/kg bw. After endotracheal intubation, inhalation anesthetic(including equal proportions of oxygen and Nitrous oxide, 4 L/min) and evaporation anesthetic (halogenated anesthetic: Isoflurane 1.2%, 1 MAC) were administered to maintainanesthesia and patients underwent mechanical ventilation using anesthesia ventilators.The patient was extubated at the end of the operation after discontinuing anesthetics and reversing the effects of the muscle relaxants using anticholineste rasessuch asneostigmine 40-70 µg/kg bw and anticholinergicssuch asintramuscular atropine 15µg/kg b w. They were then transferred to PACU (recovery room).</i_keyword>
      <i_keyword>Control group: After anesthetic monitoring of the patient, including pulse oximetry, ECG and blood pressure monitoring, minimal 500 cc crytalloids serum was intravenously administered to prevent hypotension secondary to SA. After placing the patient in a seated position and using povidone-iodine solution for sterilizing the site of lumbar puncture, the L4/L5intervertebral space was identified. A cutting-tipped 25-gauge (orange) spinal needle was inserted into the intrathecal area, and the accuracy of the technique was ensured by the appearance of cerebrospinal fluid. A total of 3 cc hyperbaric bupivacaine solution 0.5%was then injected into the subarachnoid space and the patient was placed in supine position. After stabilizing SA, the position was adjusted so as to allow the local anesthetic to move toward the T8 area. A needle or alcohol-soaked cotton was used to identify the anesthetic area and the operation began after this area was stabilized. In case of agitation during operation, 1-2 mg of intravenous midazolam was administered, and the patient was transferred to PACU after the operation.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Post operative pain. Timepoint: After 30 min. Method of measurement: visual analogue scale (VAS).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Nausea. Timepoint: 0, 6 and 12 h after the operation. Method of measurement: Visual Analogue Scale (VAS).</sec_outcome>
      <sec_outcome>Vometing. Timepoint: 0, 6 and 12 h after the operation. Method of measurement: Visual Analogue Scale (VAS).</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Semnan University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2015-11-23</approval_date>
        <contact_name>Ethics committee of Semnan University of Medical Sciences</contact_name>
        <contact_address>Basij Ave, Semnan Town Semnan Semnan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
